Please use this identifier to cite or link to this item: http://cmuir.cmu.ac.th/jspui/handle/6653943832/76979
Full metadata record
DC FieldValueLanguage
dc.contributor.authorThunwarat Suriyunen_US
dc.contributor.authorWoratree Kaewsakulthongen_US
dc.contributor.authorPinyaphat Khamphikhamen_US
dc.contributor.authorSukanya Chumchuenen_US
dc.contributor.authorSuradej Hongengen_US
dc.contributor.authorSuthat Fucharoenen_US
dc.contributor.authorOrapan Sripichaien_US
dc.date.accessioned2022-10-16T07:21:03Z-
dc.date.available2022-10-16T07:21:03Z-
dc.date.issued2021-11-01en_US
dc.identifier.issn14219662en_US
dc.identifier.issn00015792en_US
dc.identifier.other2-s2.0-85115664759en_US
dc.identifier.other10.1159/000518310en_US
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85115664759&origin=inwarden_US
dc.identifier.urihttp://cmuir.cmu.ac.th/jspui/handle/6653943832/76979-
dc.description.abstractIntroduction: β-Thalassemia/hemoglobin E represents one-half of all the clinically severe β-thalassemias worldwide. Despite similar genetic backgrounds, patients show clinical heterogeneity ranging from nearly asymptomatic to transfusion-dependent thalassemia. The underlying disease modifying factors remain largely obscure. Methods: To elucidate the correlation between ineffective erythropoiesis and β0-thalassemia/hemoglobin E (HbE) disease severity, in vitro culture of erythroid cells derived from patients with different clinical symptoms was established. Cell proliferation, viability, and differentiation were investigated. To identify potential molecular mechanisms leading to the arrested erythroid maturation, the expression levels of erythropoiesis modifying factors were measured. Results: The β0-thalassemia/HbE cells exhibited enhanced proliferation, limited differentiation, and impaired erythroid terminal maturation but did not show accelerated erythroblast differentiation and increased cell death. Erythroblasts derived from mild patients showed the highest proliferation rate with a faster cell division time, while erythroblasts derived from severe patients displayed extremely delayed erythroid maturation. Downregulation of growth differentiation factor 11 and FOXO3a was observed in mild β0-thalassemia/HbE erythroblasts, while upregulation of heat shock protein 70 and activin receptor 2A was revealed in severe erythroblasts. Discussion/Conclusion: The degree of erythroid expansion and maturation arrest contributes to the severity of β0-thalassemia/HbE patients, accounting for the disease heterogeneity. The findings suggest a restoration of erythroid maturation as a promising targeted therapy for severe patients.en_US
dc.subjectMedicineen_US
dc.titleAssociation of the Degree of Erythroid Expansion and Maturation Arrest with the Clinical Severity of β<sup>0</sup>-Thalassemia/Hemoglobin e Patientsen_US
dc.typeJournalen_US
article.title.sourcetitleActa Haematologicaen_US
article.volume144en_US
article.stream.affiliationsSiriraj Hospitalen_US
article.stream.affiliationsFaculty of Medicine Ramathibodi Hospital, Mahidol Universityen_US
article.stream.affiliationsThailand Ministry of Public Healthen_US
article.stream.affiliationsInstitute of Molecular Biosciences, Mahidol Universityen_US
article.stream.affiliationsChiang Mai Universityen_US
Appears in Collections:CMUL: Journal Articles

Files in This Item:
There are no files associated with this item.


Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.